Browse Categories

Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.

Marco Trerotola Kirat K Ganguly Ladan Fazli Carmine Fedele Huimin Lu Anindita Dutta Qin Liu Tiziana De Angelis Luke W Riddell Natalia A Riobo Martin E Gleave Amina Zoubeidi Richard G Pestell Dario C Altieri Lucia R Languino

Oncotarget

Published: October 2015

Download full-text PDF

 Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741825PMC
http://dx.doi.org/10.18632/oncotarget.6187DOI Listing

Publication Analysis

Top Keywords

erratum trop-2
4
trop-2 up-regulated
4
up-regulated invasive
4
invasive prostate
4
prostate cancer
4
cancer displaces
4
displaces fak
4
fak focal
4
focal contacts
4
erratum
1

Similar Publications

Correction: Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC).

Oncotarget

March 2020

Immunomedics, Inc., Morris Plains, NJ, USA.

David M Goldenberg Thomas M Cardillo Serengulam V Govindan Edmund A Rossi Robert M Sharkey

[This corrects the article DOI: 10.18632/oncotarget.4318.

View Article and Find Full Text PDF
Similar Publications

Correction to "DFT Provides Insight into the Additive-Free Conversion of Aqueous Methanol to Dihydrogen Catalyzed by [Ru(tropdad)]: Importance of the (Electronic) Flexibility of the Diazadiene Moiety".

J Am Chem Soc

December 2018

Vivek Sinha Monica Trincado Hansjörg Grützmacher Bas de Bruin

View Article and Find Full Text PDF
Similar Publications

Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.

Oncotarget

October 2015

Marco Trerotola Kirat K Ganguly Ladan Fazli Carmine Fedele Huimin Lu

View Article and Find Full Text PDF
Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

Privacy Policy Site Map

© LitMetric 2025. All rights reserved.